Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer.

PLoS pathogens - 1 Sept 2015

Matho Michael H, Schlossman Andrew, Meng Xiangzhi, Benhnia Mohammed Rafii-El-Idrissi, Kaever Thomas, Buller Mark, Doronin Konstantin, Parker Scott, Peters Bjoern, Crotty Shane, Xiang Yan, Zajonc Dirk M

Abstract excerpt

Vaccinia virus A33 is an extracellular enveloped virus (EEV)-specific type II membrane glycoprotein that is essential for efficient EEV formation and long-range viral spread within the host. A33 is a target for neutralizing antibody responses against EEV. In this study, we produced seven murine anti-A33 monoclonal antibodies (MAbs) by immunizing mice with live VACV, followed by boosting with the soluble A33...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Antibody Affinity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antibody Specificity

Share to Antigen-Antibody Complex

Share to Immunoglobulin Fab Fragments

Share to Vaccines, Synthetic

Share to Viral Tropism

Share to Viral Vaccines

Source

Open in PubMed Open full text

Identifiers

PMID: 26325270
DOI: 10.1371/journal.ppat.1005148
PMCID: PMC4556652

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer.PMID 26325270Read ↗

Discovery, recognized antigenic structures, and evolution of cross-serotype broadly neutralizing antibodies from porcine B-cell repertoires against foot-and-mouth disease virusSemantic proximity Read ↗

Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infectionsSemantic proximity Read ↗

Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalkSemantic proximity Read ↗

Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site.Semantic proximity Read ↗

Computational rescue of antibody binding to monkeypox virus E8L: from electrostatic repulsion to salt bridge-enhanced affinity.Semantic proximity Read ↗

Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response.Semantic proximity Read ↗

Discovery of potent cross-neutralizing antibodies for the treatment of Marburg virus diseaseSemantic proximity Read ↗

Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins.Semantic proximity Read ↗

Structural basis for broad neutralization of ebolaviruses by an antibody targeting the glycoprotein fusion loopSemantic proximity Read ↗

Characterization of Antibody Interactions with the G Protein of Vesicular Stomatitis Virus Indiana Strain and Other Vesiculovirus G ProteinsSemantic proximity Read ↗

A detailed mutagenesis study of flavivirus cross-reactive epitopes using West Nile virus-like particlesSemantic proximity Read ↗

Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.